Kamran Hooman, Tafazoli Nooshin, Eftekharzadeh Sahar, Samaei Mehrnoosh, Kajbafzadeh Abdol-Mohammad
Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, No.62, Dr. Gharib's Street, Keshavarz Boulevard, P.O. Box: 1419733151, Tehran, Iran.
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Int Urol Nephrol. 2023 Jun;55(6):1403-1411. doi: 10.1007/s11255-023-03596-z. Epub 2023 Apr 21.
The aim of this report is to evaluate the efficacy of endoscopic injection of calcium hydroxyapatite (CaHA) into the bladder neck and posterior urethra in children with refractory urinary incontinence due to spinal dysraphism.
A retrospective study was performed on patients with neuropathic bladder due to spinal dysraphism who had undergone submucosal urethral injections of CaHA from 2010 until 2019. All patients were totally incontinent without voiding per urethra and did not respond to 1-year standard pharmacotherapy with anticholinergic drugs. All children underwent a precise physical exam and urodynamic studies. Patients underwent urethrocystoscopy and injection of pure soluble CaHA into the bladder neck and posterior urethra except for the verumontanum. The outcomes were determined as no change, improvement (social continent), or cure (total continent).
Fifteen children (ten boys, five girls, mean age of 7.6 years) with a history of spinal dysraphism and refractory urinary incontinence were included. Endoscopic injections of CaHA were performed one or two times for each patient. At the median follow-up of 2 years (interquartile range = 6), seven (46.7%), three (20.0%), and five (33.3%) of the patients were total continent, social continent, and total incontinent, respectively. In four patients, intradetrusor botulinum toxin injection was performed simultaneously with CaHA injection. Also, one patient experienced a febrile urinary tract infection between two CaHA injections. Among 15 patients, 9 had atonic/hypotonic bladders both before and after CaHA injections; at the last follow-up, 4 of these children (44.4%) were totally continent. No injection-related or other complications were observed in the patients.
Injection of CaHA into the bladder neck is relatively safe, reproducible, and effective for total dribbling urinary incontinence in children with spinal dysraphism. The bladder neck reconstruction with or without a urethral sling or other surgical procedures could be postponed until puberty in selected cases. However, further multicenter clinical trials are highly recommended.
本报告旨在评估内镜下向患有脊柱裂导致的难治性尿失禁儿童的膀胱颈和后尿道注射羟基磷灰石钙(CaHA)的疗效。
对2010年至2019年期间因脊柱裂接受CaHA尿道黏膜下注射的神经性膀胱患者进行回顾性研究。所有患者均完全尿失禁,不能经尿道排尿,且对1年的抗胆碱能药物标准药物治疗无反应。所有儿童均接受了精确的体格检查和尿动力学研究。患者接受尿道膀胱镜检查,并将纯可溶性CaHA注射到膀胱颈和后尿道,但不包括精阜。结果分为无变化、改善(社交性控尿)或治愈(完全控尿)。
纳入15名有脊柱裂病史和难治性尿失禁的儿童(10名男孩,5名女孩,平均年龄7.6岁)。每位患者接受了1或2次CaHA内镜注射。中位随访2年(四分位间距=6)时,分别有7名(46.7%)、3名(20.0%)和5名(33.3%)患者完全控尿、社交性控尿和完全尿失禁。4名患者在注射CaHA的同时进行了膀胱逼尿肌内注射肉毒杆菌毒素。此外,1名患者在两次CaHA注射之间发生了发热性尿路感染。15名患者中,9名在CaHA注射前后均有张力缺乏/低张力膀胱;在最后一次随访时,这些儿童中有4名(44.4%)完全控尿。患者未观察到与注射相关或其他并发症。
向膀胱颈注射CaHA对于脊柱裂儿童的完全滴漏性尿失禁相对安全、可重复且有效。在某些情况下,可将有或无尿道吊带或其他手术的膀胱颈重建推迟到青春期。然而,强烈建议进一步开展多中心临床试验。